The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
Open accessAbstract
Introduction: We analyzed the prevalence of cardiovascular (CV) disease in patients with rheumatoid arthritis (RA) and its association with traditional CV risk factors, clinical features of RA, and the use of disease-modifying antirheumatic drugs (DMARDs) in a multinational cross-sectional cohort of nonselected consecutive outpatients with RA (The Questionnaires in Standard Monitoring of Patients with Rheumatoid Arthritis Program, or QUEST-RA) who were receiving regular clinical care. Methods: The study involved a clinical assessment by a rheumatologist and a self-report questionnaire by patients. The clinical assessment included a review of clinical features of RA and exposure to DMARDs over the course of RA. Comorbidities were recorded; CV morbidity included myocardial infarction, angina, coronary disease, coronary bypass surgery, and stroke. Traditional risk factors recorded were hypertension, hyperlipidemia, diabetes mellitus, smoking, physical inactivity, and body mass index. Unadjusted and adjusted hazard ratios (HRs) (95% confidence interval [CI]) for CV morbidity were calculated using Cox proportional hazard regression models. Results: Between January 2005 and October 2006, the QUEST-RA project included 4,363 patients from 48 sites in 15 countries; 78% were female, more than 90% were Caucasian, and the mean age was 57 years. The prevalence for lifetime CV events in the entire sample was 3.2% for myocardial infarction, 1.9% for stroke, and 9.3% for any CV event. The prevalence for CV risk factors was 32% for hypertension, 14% for hyperlipidemia, 8% for diabetes, 43% for ever-smoking, 73% for physical inactivity, and 18% for obesity. Traditional risk factors except obesity and physical inactivity were significantly associated with CV morbidity. There was an association between any CV event and age and male gender and between extra-articular disease and myocardial infarction. Prolonged exposure to methotrexate (HR 0.85; 95% CI 0.81 to 0.89), leflunomide (HR 0.59; 95% CI 0.43 to 0.79), sulfasalazine (HR 0.92; 95% CI 0.87 to 0.98), glucocorticoids (HR 0.95; 95% CI 0.92 to 0.98), and biologic agents (HR 0.42; 95% CI 0.21 to 0.81; P < 0.05) was associated with a reduction of the risk of CV morbidity; analyses were adjusted for traditional risk factors and countries. Conclusion: In conclusion, prolonged use of treatments such as methotrexate, sulfasalazine, leflunomide, glucocorticoids, and tumor necrosis factor-alpha blockers appears to be associated with a reduced risk of CV disease. In addition to traditional risk factors, extra-articular disease was associated with the occurrence of myocardial infarction in patients with RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Measurement of patient outcome in arthritis
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230202 · Cited by 4,382
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
Walking Compared with Vigorous Exercise for the Prevention of Cardiovascular Events in Women
Manson, J. E., Greenland, P., LaCroix, A. Z., Stefanick, M. L., Mouton, C. P., Oberman, A., Perri, M. G., Sheps, D. S., Pettinger, M. B., & Siscovick, D. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021067 · Cited by 1,330
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis
Solomon, D. H., Karlson, E. W., Rimm, E. B., Cannuscio, C. C., Mandl, L. A., Manson, J. E., Stampfer, M. J., & Curhan, G. C. (2003) · Circulation · doi:10.1161/01.cir.0000054612.26458.b2 · Cited by 1,246
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
Jüni, P., Nartey, L., Reichenbach, S., Sterchi, R., Dieppe, P. A., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17514-4 · Cited by 846
Han, C., Robinson, D., Hackett, M., Paramore, L. C., Fraeman, K. H., & BALA, M. M. (2006) · PubMed · Cited by 721
Hürlimann, D., Forster, A., Noll, G., Enseleit, F., Chenevard, R., Distler, O., Béchir, M., Spieker, L. E., Neidhart, M., Michel, B. A., et al. (2002) · Circulation · doi:10.1161/01.cir.0000037521.71373.44 · Cited by 574
Dixon, W. G., Watson, K. D., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22809 · Cited by 562
Jacobsson, L., Turesson, C., Gülfe, A., Kapetanovic, M. C., Petersson, I. F., Saxne, T., & Geborek, P. (2005) · PubMed · Cited by 533
Patterns of cardiovascular risk in rheumatoid arthritis
Solomon, D. H., Goodson, N. J., Katz, J. N., Weinblatt, M. E., Avorn, J., Setoguchi, S., Canning, C., & Schneeweiss, S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.050377 · Cited by 412
Wållberg‐Jonsson, S., Johansson, H., Ohman, M. L., & Rantapää‐Dahlqvist, S. (1999) · PubMed · Cited by 409
Goodson, N. J., Wiles, N. J., Lunt, M., Barrett, E. M., Silman, A. J., & Symmons, D. P. M. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10419 · Cited by 366
Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis.
Wolfe, F., Freundlich, B., & Straus, W. L. (2003) · PubMed · Cited by 355
Sokka, T., Häkkinen, A., Kautiainen, H., Maillefert, J. F., Toloza, S., MØrk hansen, T., Calvo‐Alen, J., Oding, R., Liveborn, M., Huisman, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23255 · Cited by 354
Self-citationChung, C. P., Oeser, A., Raggi, P., Gebretsadik, T., Shintani, A. K., Sokka, T., Pincus, T., Avalos, I., & Stein, C. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21288 · Cited by 354
Self-citationKumeda, Y., Inaba, M., Goto, H., Nagata, M., Henmi, Y., Furumitsu, Y., Ishimura, E., Inui, K., Yutani, Y., Miki, T., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10269 · Cited by 313
Smoking and the risk of rheumatoid arthritis.
Silman, A. J. (1993) · PubMed · Cited by 306
Preclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis
Roman, M. J., Moeller, E., Davis, A., Paget, S. A., Crow, M. K., Lockshin, M. D., Sammaritano, L., Devereux, R. B., Schwartz, J. E., Levine, D. M., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-4-200602210-00006 · Cited by 294
Johnsen, S. P. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.9.978 · Cited by 288
Goodson, N. J., Symmons, D. P. M., Scott, D. G. I., Bunn, D., Lunt, M., & Silman, A. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21204 · Cited by 287
Smoking and risk of rheumatoid arthritis.
Heliövaara, M., Aho, K., Aromaa, A., Knekt, P., & Reunanen, A. (1993) · PubMed · Cited by 286
Dominguez, H., Storgaard, H., Rask-Madsen, C., Steffen Hermann, T., Ihlemann, N., Baunbjerg Nielsen, D., Spohr, C., Kober, L., Vaag, A., & Torp-Pedersen, C. (2005) · Journal of Vascular Research · doi:10.1159/000088261 · Cited by 286
Watson, D. J., Rhodes, T., & Guess, H. A. (2003) · PubMed · Cited by 284
Extra-articular rheumatoid arthritis: prevalence and mortality
Turesson, C. (1999) · Rheumatology · doi:10.1093/rheumatology/38.7.668 · Cited by 271
van Halm, V. P., Nurmohamed, M. T., Twisk, J. W., Dijkmans, B. A., & Voskuyl, A. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2045 · Cited by 267
Turesson, C., Jarenros, A., & Jacobsson, L. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018101 · Cited by 261
Goodson, N., Marks, J., Lunt, M., & Symmons, D. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.034777 · Cited by 248
Georgiadis, A. N., Papavasiliou, E. C., Lourida, E. S., Alamanos, Y., Kostara, C., Tselepis, A. D., & Drosos, A. A. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1952 · Cited by 247
Dessein, P. H., Joffe, B. I., Veller, M., Stevens, B., Tobias, M., Reddi, K., & Stanwix, A. E. (2005) · PubMed · Cited by 235
Glucocorticoids and cardiovascular events in rheumatoid arthritis: A population‐based cohort study
Davis, J. M., Maradit Kremers, H., Crowson, C. S., Nicola, P. J., Ballman, K. V., Therneau, T. M., Roger, V. L., & Gabriel, S. E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22418 · Cited by 233
Carmona, L., Descalzo, M. Á., Perez-Pampin, E., Ruiz-Montesinos, D., Erra, A., Cobo, T., & Gómez-Reino, J. J. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.067660 · Cited by 231
Self-citationGonzalez‐Juanatey, C., Testa, A., Garcia‐Castelo, A., Garcia‐Porrua, C., Llorca, J., & Gonzalez‐Gay, M. A. (2004) · Arthritis Care & Research · doi:10.1002/art.20407 · Cited by 227
Sokka, T., Kautiainen, H., Toloza, S., Mäkinen, H., Verstappen, S. M. M., Lund Hetland, M., Naranjo, A., Baecklund, E., Herborn, G., Rau, R., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.069252 · Cited by 220
Self-citationImpaired Responsiveness to NO in Newly Diagnosed Patients With Rheumatoid Arthritis
Bergholm, R., Leirisalo-Repo, M., Vehkavaara, S., Mäkimattila, S., Taskinen, M.-R., & Yki-Järvinen, H. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000033516.73864.4e · Cited by 214
Antirheumatic drug use and the risk of acute myocardial infarction
Suissa, S., Bernatsky, S., & Hudson, M. (2006) · Arthritis Care & Research · doi:10.1002/art.22094 · Cited by 184
Solomon, D. H., Avorn, J., Katz, J. N., Weinblatt, M. E., Setoguchi, S., Levin, R., & Schneeweiss, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22255 · Cited by 181
Turesson, C., McClelland, R. L., Christianson, T. J. H., & Matteson, E. L. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.052506 · Cited by 174
Accelerated atherogenesis in autoimmune rheumatic diseases
Bacon, P. A., Stevens, R. J., Carruthers, D. M., Young, S. P., & Kitas, G. D. (2002) · Autoimmunity Reviews · doi:10.1016/s1568-9972(02)00100-3 · Cited by 155
Corticosteroids: do they damage the cardiovascular system?
Maxwell, S. R. J., Moots, R. J., & Kendall, M. J. (1994) · Postgraduate Medical Journal · doi:10.1136/pgmj.70.830.863 · Cited by 154
Warrington, K. J., Kent, P. D., Frye, R. L., Lymp, J. F., Kopecky, S. L., Goronzy, J. J., & Weyand, C. M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1775 · Cited by 150
Knoops, K. T. B., de Groot, L. C. P. G. M., Kromhout, D., Perrin, A.-E., Moreiras-Varela, O., Menotti, A., & van Staveren, W. A. (2004) · JAMA · doi:10.1001/jama.292.12.1433 · Cited by 146
Cardiovascular disease in rheumatoid arthritis
Kaplan, M. J. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000218951.65601.bf · Cited by 135
Liang, K., Liang, K., Matteson, E., McClelland, R., Christianson, T. J. H., & Turesson, C. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21628 · Cited by 99
Troelsen, L. N., Garred, P., MADSEN, H. O., & Jacobsen, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22302 · Cited by 61
Rheumatoid arthritis databases
Sokka, T. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.07.003 · Cited by 15
Self-citationImpact of parental history on patients' cardiovascular mortality in rheumatoid arthritis
Björnådal, L., Brandt, L., Klareskog, L., & Askling, J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.039990 · Cited by 11
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Targeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Peters, M. J. L., Symmons, D. P. M., McCarey, D., Dijkmans, B. A. C., Nicola, P., Kvien, T. K., McInnes, I. B., Haentzschel, H., Gonzalez-Gay, M. A., Provan, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.113696 · Cited by 1,325
Dougados, M., Soubrier, M., Antunez, A., Balint, P., Balsa, A., Buch, M. H., Casado, G., Detert, J., El-zorkany, B., Emery, P., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204223 · Cited by 855
Obesity in autoimmune diseases: Not a passive bystander
Versini, M., Jeandel, P.-Y., Rosenthal, E., & Shoenfeld, Y. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.07.001 · Cited by 694
Recent Advances on the Role of Cytokines in Atherosclerosis
Ait-Oufella, H., Taleb, S., Mallat, Z., & Tedgui, A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207415 · Cited by 578
Metadata
- Authors
- Naranjo, A., Sokka, T., Descalzo, M. A., Calvo-Alén, J., Hørslev-Petersen, K., Luukkainen, R. K., Combe, B., Burmester, G. R., Devlin, J., Ferraccioli, G., Morelli, A., Hoekstra, M., Majdan, M., Sadkiewicz, S., Belmonte, M., Holmqvist, A.-C., Choy, E., Tunc, R., Dimic, A., Bergman, M., Toloza, S., Pincus, T., & the QUEST-RA Group
- Venue
- Arthritis Research & Therapy
- Published
- 2008-03-06
- Volume
- 10
- Issue
- 2
- Pages
- R30-R30
- ISSN
- 1478-6354 (ISSN-L)
- OpenAlex
- W2068985697
- Cited by
- 467
- References
- 50
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.